MyMD Pharmaceuticals (MYMD) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free MYMD Stock Alerts $2.19 +0.09 (+4.29%) (As of 01:52 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media MyMD Pharmaceuticals Short Interest DataCurrent Short Volume214,300 sharesPrevious Short Volume393,000 sharesChange Vs. Previous Month-45.47%Dollar Volume Sold Short$660,044.00Short Interest Ratio / Days to Cover1.0Last Record DateApril 30, 2024Outstanding Shares2,160,000 sharesFloat Size1,980,000 sharesShort Percent of Float10.82%Today's Trading Volume24,794 sharesAverage Trading Volume164,964 sharesToday's Volume Vs. Average15% Short Selling MyMD Pharmaceuticals ? Sign up to receive the latest short interest report for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMYMD Short Interest Over TimeMYMD Days to Cover Over TimeMYMD Percentage of Float Shorted Over Time Ad Unstoppable ProsperityCharles Payne Demystifies OptionsWhen it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. MyMD Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024214,300 shares $660,044.00 -45.5%10.8%1 $3.08 4/15/2024393,000 shares $892,110.00 +260.2%20.6%1.8 $2.27 3/31/2024109,100 shares $260,749.00 +16.8%5.7%0.5 $2.39 3/15/202493,400 shares $268,992.00 +0.8%5.1%1.7 $2.88 2/29/202492,700 shares $317,961.00 -5.4%5.2%1.6 $3.43 2/15/202498,000 shares $320,460.00 -95.9%5.5%1.7 $3.27 Get the Latest News and Ratings for MYMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MyMD Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,400,000 shares $360,000.00 -32.4%5.5%1.6 $0.15 1/15/20243,550,000 shares $699,350.00 +3.2%8.2%2.5 $0.20 12/31/20233,440,000 shares $889,928.00 +8.2%7.9%2.8 $0.26 12/15/20233,180,000 shares $731,400.00 -19.5%7.3%3.7 $0.23 11/30/20233,950,000 shares $1.11 million +17.9%9.3%5.4 $0.28 11/15/20233,350,000 shares $1.17 million +2.1%7.9%5.1 $0.35 10/31/20233,280,000 shares $1.39 million -9.6%8.7%5.4 $0.43 10/15/20233,630,000 shares $1.53 million +4.0%9.7%4.5 $0.42 9/30/20233,490,000 shares $2.07 million +19.1%9.3%4.1 $0.59 9/15/20232,930,000 shares $1.80 million -0.7%7.8%3.8 $0.61 8/31/20232,950,000 shares $2.81 million +7.7%8.0%4.1 $0.95 8/15/20232,740,000 shares $3.49 million -32.0%7.4%3.8 $1.28 7/31/20234,030,000 shares $5.84 million +13.8%12.0%5.6 $1.45 7/15/20233,540,000 shares $2.83 million -1.7%10.6%6.7 $0.80 6/30/20233,600,000 shares $5.40 million -2.7%10.7%7.4 $1.50 6/15/20233,700,000 shares $6.07 million +3.9%11.3%7.5 $1.64 5/31/20233,560,000 shares $6.19 million +11.3%10.9%6.5 $1.74 5/15/20233,200,000 shares $6.11 million -0.6%9.8%6.1 $1.91 4/30/20233,220,000 shares $5.83 million +6.3%9.9%6.4 $1.81 4/15/20233,030,000 shares $4.67 million +2.0%9.3%6 $1.54 3/31/20232,970,000 shares $5.11 million +44.2%9.1%6.4 $1.72 3/15/20232,060,000 shares $3.63 million +48.2%6.4%5.3 $1.76 2/28/20231,390,000 shares $2.65 million +47.8%4.3%4.6 $1.91 2/15/2023940,500 shares $2.17 million +18.7%2.9%3.7 $2.31 1/31/2023792,200 shares $2.14 million +9.8%2.4%3.4 $2.70 1/15/2023721,600 shares $1.10 million -1.1%2.2%4.4 $1.52 12/30/2022729,900 shares $839,385.00 -14.8%2.3%4.6 $1.15 12/15/2022856,600 shares $1.16 million -5.1%2.6%5.1 $1.35 11/30/2022902,400 shares $1.93 million +25.8%2.8%5.2 $2.14 11/15/2022717,200 shares $1.43 million +3.4%2.2%4.2 $1.99 10/31/2022693,800 shares $1.92 million +1.5%2.1%3.2 $2.77 10/15/2022683,400 shares $1.58 million +1.6%2.1%2.8 $2.31 9/30/2022672,900 shares $1.76 million +5.4%2.1%2.4 $2.61 9/15/2022638,700 shares $2.22 million -6.4%2.0%2.1 $3.48The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him MYMD Short Interest - Frequently Asked Questions What is MyMD Pharmaceuticals' current short interest? Short interest is the volume of MyMD Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 214,300 shares of MYMD short. 10.82% of MyMD Pharmaceuticals' shares are currently sold short. Learn More on MyMD Pharmaceuticals' current short interest. What is a good short interest ratio for MyMD Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MYMD shares currently have a short interest ratio of 1.0. Learn More on MyMD Pharmaceuticals's short interest ratio. What is a good short interest percentage for MyMD Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.82% of MyMD Pharmaceuticals' floating shares are currently sold short. Is MyMD Pharmaceuticals' short interest increasing or decreasing? MyMD Pharmaceuticals saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 214,300 shares, a decrease of 45.5% from the previous total of 393,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is MyMD Pharmaceuticals' float size? MyMD Pharmaceuticals currently has issued a total of 2,160,000 shares. Some of MyMD Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MyMD Pharmaceuticals currently has a public float of 1,980,000 shares. How does MyMD Pharmaceuticals' short interest compare to its competitors? 10.82% of MyMD Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to MyMD Pharmaceuticals: Biomerica, Inc. (0.64%), Trinity Biotech plc (0.02%), Cardio Diagnostics Holdings, Inc. (1.92%), Shineco, Inc. (0.48%), Kintara Therapeutics, Inc. (10.35%), BIOLASE, Inc. (0.91%), Silo Pharma, Inc. (5.69%), Cingulate Inc. (0.20%), Kazia Therapeutics Limited (0.53%), Heart Test Laboratories, Inc. (1.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short MyMD Pharmaceuticals stock? Short selling MYMD is an investing strategy that aims to generate trading profit from MyMD Pharmaceuticals as its price is falling. MYMD shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MyMD Pharmaceuticals? A short squeeze for MyMD Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MYMD, which in turn drives the price of the stock up even further. How often is MyMD Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYMD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BMRA Short Squeeze TRIB Short Squeeze CDIO Short Squeeze SISI Short Squeeze KTRA Short Squeeze BIOL Short Squeeze SILO Short Squeeze CING Short Squeeze KZIA Short Squeeze HSCS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MYMD) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch Gold